Samal, S.K.; Qureshi, A.R.; Rahman, M.; Stenvinkel, P.; Frostegård, J.
Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes. J. Clin. Med. 2020, 9, 753.
https://doi.org/10.3390/jcm9030753
AMA Style
Samal SK, Qureshi AR, Rahman M, Stenvinkel P, Frostegård J.
Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes. Journal of Clinical Medicine. 2020; 9(3):753.
https://doi.org/10.3390/jcm9030753
Chicago/Turabian Style
Samal, Shailesh Kumar, Abdul Rashid Qureshi, Mizanur Rahman, Peter Stenvinkel, and Johan Frostegård.
2020. "Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes" Journal of Clinical Medicine 9, no. 3: 753.
https://doi.org/10.3390/jcm9030753
APA Style
Samal, S. K., Qureshi, A. R., Rahman, M., Stenvinkel, P., & Frostegård, J.
(2020). Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes. Journal of Clinical Medicine, 9(3), 753.
https://doi.org/10.3390/jcm9030753